Purchase Order AG4232P160046
- Not listed
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) to Otogenetics Corporation, a minority-owned, small disadvantaged, woman-owned business. The $15,999 firm fixed-price purchase order was for next-generation sequencing laboratory services, including whole exome sequencing, clinical genetic testing, and data analysis to support NIH research programs. Otogenetics has been awarded multiple federal...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Otogenetics Corporation, a minority-owned, small disadvantaged business, for laboratory supplies and other functions. The contract has a ceiling value of $80,000.00 and a period of performance that ends on April 1, 2016. Otogenetics Corporation is a next-generation sequencing laboratory service provider that specializes in services such as whole exome...
- Otogenetics Corporation, a minority-owned, small disadvantaged business, has been awarded a $24,849 firm-fixed-price purchase order contract by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases. The contract, which is not set aside for any specific business category, is for the provision of next-generation sequencing laboratory services, including whole exome sequencing, clinical genetic testing, and data analysis, to support research...
- The U.S. federal government awarded a $31,368 purchase order to Psomagen Inc., a genomics and molecular biology services company headquartered in Rockville, Maryland, for Illumina High-Seq 2x150bp sequencing services generating gigabase output per lane. The contract, awarded on September 6, 2019, with an ultimate completion date of September 20, 2019, was issued without set-aside designation and was funded through a civilian federal agency's Southeast Area office. Work was performed at a...
- The U.S. government awarded a $22.44K purchase order to Novogene Corporation Inc., a minority-owned small business specializing in genomic sequencing services, for RNA sequencing and library preparation services. The contract, awarded on September 6, 2019, with an ultimate completion date of July 5, 2020, covers 30 samples requiring strand-specific library preparation with ribosomal RNA removal, small RNA sequencing at 20 million raw reads per sample, and 18 gigabytes of raw data per sample with...
- The U.S. government awarded a $2,868.00 purchase order to Novogene Corporation Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The contract, issued on January 13, 2021, with completion targeted for July 14, 2021, covers RNA sequencing services to be performed in Chula Vista, California. This firm fixed-price purchase order was funded by a civilian federal agency and was not designated as a set-aside contract. Novogene, headquartered in...
- This federal contract award represents a Purchase Order issued on November 16, 2020, by a civilian federal agency within the Southeast Area to Novogene Corporation Inc. for RNA sequencing services. The contract, valued at $7,450.00 with a firm fixed price structure, is scheduled for completion by May 17, 2021, with performance taking place in New Orleans, Louisiana. No small business set-aside was applied to this award. Novogene Corporation Inc., a minority-owned small business headquartered...
- The U.S. government awarded a $7,065 firm fixed-price purchase order to Novogene Corporation Inc. on August 30, 2018, for RNA sequencing, library preparation, and six gigabytes of raw sequencing data per sample services. The contract, based on Novogene's quote dated July 9, 2018, was issued under the simplified acquisition threshold procedures for purchases under $25,000 and did not utilize a small business set-aside designation. Work was completed by April 16, 2019, with services performed in...
- This purchase order, awarded July 27, 2018, to Novogene Corporation Inc., a minority-owned small business specializing in genomic sequencing services, covers eukaryotic RNA sequencing (RNA-seq) library preparation and sequencing for 44 samples. The contract, valued at $15,066, represents a firm fixed-price engagement with a completion date of October 30, 2018. Work will be performed in Chula Vista, California, and is funded through a civilian federal agency's Southeast Area office. No small...
- The U.S. government awarded a $38,250 firm fixed-price purchase order to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business, for genome sequencing services utilizing RNA sequencing (RNAseq) technology. The contract was awarded on April 28, 2023, following a competitive solicitation posted on April 19, 2023, with a five-day turnaround to submission. Work will be performed in Auburn, Alabama, with a completion date extended to December 31, 2023, via modification P00001....
The U.S. government awarded a $24,997 purchase order to Otogenetics Corporation for RNA sequencing (RNA SEQ) services. This firm fixed-price contract was executed on April 26, 2016, with a completion date of May 6, 2016, and was performed at the company's facility in Dunwoody, Georgia. The contract was funded by a civilian federal agency within the Southeast Area and was not designated as a set-aside for any specific business category. Otogenetics Corporation is a next-generation sequencing laboratory service provider specializing in exome sequencing, clinical genetic testing, and genomic analysis services. The company has established a significant relationship with the National Institutes of Health, including a $100 million blanket purchase agreement awarded in April 2021 for specialized laboratory testing and sequencing services. This particular purchase order represents one of several federal contracts through which Otogenetics has provided critical sequencing and data analysis support for NIH-funded research initiatives focused on areas including arthritis, musculoskeletal disorders, and skin diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 4/26/16 |